TF and neoplasm: Injection of two doses of 20 μg rVEGF-TF in mice bearing CT26 colon carcinoma xenografts resulted in a significant decrease in tumor growth and complete regression of tumor mass in 20% of mice by 2 weeks after the first treatment [5].